title: Salmon and human thrombin differentially regulate radicular pain, glial-induced inflammation and spinal neuronal excitability through protease-activated receptor-1.
abstract: Chronic neck pain is a major problem with common causes including disc herniation and spondylosis that compress the spinal nerve roots. Cervical nerve root compression in the rat produces sustained behavioral hypersensitivity, due in part to the early upregulation of pro-inflammatory cytokines, the sustained hyperexcitability of neurons in the spinal cord and degeneration in the injured nerve root. Through its activation of the protease-activated receptor-1 (PAR1), mammalian thrombin can enhance pain and inflammation; yet at lower concentrations it is also capable of transiently attenuating pain which suggests that PAR1 activation rate may affect pain maintenance. Interestingly, salmon-derived fibrin, which contains salmon thrombin, attenuates nerve root-induced pain and inflammation, but the mechanisms of action leading to its analgesia are unknown. This study evaluates the effects of salmon thrombin on nerve root-mediated pain, axonal degeneration in the root, spinal neuronal hyperexcitability and inflammation compared to its human counterpart in the context of their enzymatic capabilities towards coagulation substrates and PAR1. Salmon thrombin significantly reduces behavioral sensitivity, preserves neuronal myelination, reduces macrophage infiltration in the injured nerve root and significantly decreases spinal neuronal hyperexcitability after painful root compression in the rat; whereas human thrombin has no effect. Unlike salmon thrombin, human thrombin upregulates the transcription of IL-1β and TNF-α and the secretion of IL-6 by cortical cultures. Salmon and human thrombins cleave human fibrinogen-derived peptides and form clots with fibrinogen with similar enzymatic activities, but salmon thrombin retains a higher enzymatic activity towards coagulation substrates in the presence of antithrombin III and hirudin compared to human thrombin. Conversely, salmon thrombin activates a PAR1-derived peptide more weakly than human thrombin. These results are the first to demonstrate that salmon thrombin has unique analgesic, neuroprotective and anti-inflammatory capabilities compared to human thrombin and that PAR1 may contribute to these actions.
authors.affiliation: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
authors.forename: Jenell R
authors.initials: JR
authors.lastname: Smith
authors.forename: Peter P
authors.initials: PP
authors.lastname: Syre
authors.forename: Shaina A
authors.initials: SA
authors.lastname: Oake
authors.forename: Kristen J
authors.initials: KJ
authors.lastname: Nicholson
authors.forename: Christine L
authors.initials: CL
authors.lastname: Weisshaar
authors.forename: Katrina
authors.initials: K
authors.lastname: Cruz
authors.forename: Robert
authors.initials: R
authors.lastname: Bucki
authors.forename: Bethany C
authors.initials: BC
authors.lastname: Baumann
authors.forename: Paul A
authors.initials: PA
authors.lastname: Janmey
authors.forename: Beth A
authors.initials: BA
authors.lastname: Winkelstein
mesh_terms: D000818:Animals; D001483:Base Sequence; D001777:Blood Coagulation; D017931:DNA Primers; D004797:Enzyme-Linked Immunosorbent Assay; D005071:Evoked Potentials; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D007700:Kinetics; D009474:Neurons / Q000473:pathology*; D010146:Pain / Q000503:physiopathology*; D011843:Radiculopathy / Q000503:physiopathology; D060888:Real-Time Polymerase Chain Reaction; D044463:Receptor, PAR-1 / Q000502:physiology*; D012474:Salmon / Q000378:metabolism*; D013116:Spinal Cord / Q000473:pathology* / Q000503:physiopathology; D013917:Thrombin / Q000502:physiology*
chemical_list: D017931:DNA Primers; D044463:Receptor, PAR-1; D013917:Thrombin